參考文獻(xiàn)/References:
[1] 錢會(huì)南.《黃帝內(nèi)經(jīng)》十三方的后世臨床運(yùn)用啟示[J].安徽中醫(yī)藥大學(xué)學(xué)報(bào), 2023, 42(3):1-4.
[2] Fang S, Dong L, Liu L, et al.HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine[J].Nucleic Acids Res, 2021, 49(D1):D1197-D1206.
[3] Gfeller D, Grosdidier A, Wirth M, et al.Swiss target prediction: a web server for target prediction of bioactive small molecules[J].Nucleic Acids Res, 2014, 42(Web Server issue):W32-38.
[4] Franceschini A, Szklarczyk D, Frankild S, et al.STRING v9.1: protein-protein interaction networks, with increased coverage and integration[J].Nucleic Acids Res, 2013, 41(Database issue):D808-815.
[5] Zhou Y, Zhou B, Pache L, et al.Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J].Nat Commun, 2019, 10(1):1523.
[6] Zhang D Y, Yao X H, Duan M H, et al.An effective homogenate-assisted negative pressure cavitation extraction for the determination of phenolic compounds in pyrola by LC-MS/MS and the evaluation of its antioxidant activity[J].Food Funct, 2015, 6(10):3323-3333.
[7] 高改, 李二穩(wěn), 王夢(mèng)瑤, 等.基于SREBPs的澤瀉活性成分及其降脂作用研究[J].時(shí)珍國醫(yī)國藥, 2022, 33(3):521-526.
[8] 顏培正, 孟慶巖, 常興, 等.《黃帝內(nèi)經(jīng)》“酒風(fēng)”病因病機(jī)探析[J].中國中醫(yī)基礎(chǔ)醫(yī)學(xué)雜志, 2017, 23(2):149-150,155.
[9] 謝治深, 黃小虹, 袁永, 等.澤瀉抑制脂多糖誘導(dǎo)的RAW264.7炎癥及作用機(jī)制[J].時(shí)珍國醫(yī)國藥, 2020, 31(7):1586-1590.
[10] 陳琴華, 余飛, 王紅梅, 等.白術(shù)內(nèi)酯Ⅰ、Ⅱ、Ⅲ對(duì)炎性巨噬細(xì)胞細(xì)胞因子表達(dá)的影響[J].中國藥師, 2017, 20(12):2112-2116.
[11] Chen Y, Yang W, Guo L, et al.Atractylodes lactone compounds inhibit platelet activation[J].Platelets, 2017, 28(2):194-202.
[12] 郭雨雅, 孫曉琦, 方晶, 等.加味澤瀉湯對(duì)NAFLD大鼠肝臟炎癥信號(hào)通路相關(guān)蛋白表達(dá)的影響[J].中國實(shí)驗(yàn)方劑學(xué)雜志, 2017, 23(5):90-94.
[13] Matsushita T, Sasaki H, Takayama K, et al.The overexpression of SIRT1 inhibited osteoarthritic gene expression changes induced by interleukin-1β in human chondrocytes[J].J Orthop Res, 2013, 31(4):531-537.